[go: up one dir, main page]

AU2002353122B2 - Pyranoindazoles and their use for the treatment of glaucoma - Google Patents

Pyranoindazoles and their use for the treatment of glaucoma Download PDF

Info

Publication number
AU2002353122B2
AU2002353122B2 AU2002353122A AU2002353122A AU2002353122B2 AU 2002353122 B2 AU2002353122 B2 AU 2002353122B2 AU 2002353122 A AU2002353122 A AU 2002353122A AU 2002353122 A AU2002353122 A AU 2002353122A AU 2002353122 B2 AU2002353122 B2 AU 2002353122B2
Authority
AU
Australia
Prior art keywords
indazol
pyrano
aminopropyl
tetrahydro
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002353122A
Other languages
English (en)
Other versions
AU2002353122A1 (en
Inventor
Hwang-Hsing Chen
Jesse A. May
Bryon S. Severns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AU2002353122A1 publication Critical patent/AU2002353122A1/en
Application granted granted Critical
Publication of AU2002353122B2 publication Critical patent/AU2002353122B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002353122A 2002-05-30 2002-12-11 Pyranoindazoles and their use for the treatment of glaucoma Ceased AU2002353122B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1686102A 2002-05-30 2002-05-30
US02/016,861 2002-05-30
PCT/US2002/039666 WO2003101379A2 (fr) 2002-05-30 2002-12-11 Pyranoindazoles et leur utilisation pour le traitement du glaucome

Publications (2)

Publication Number Publication Date
AU2002353122A1 AU2002353122A1 (en) 2003-12-19
AU2002353122B2 true AU2002353122B2 (en) 2008-01-31

Family

ID=29709135

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002353122A Ceased AU2002353122B2 (en) 2002-05-30 2002-12-11 Pyranoindazoles and their use for the treatment of glaucoma

Country Status (7)

Country Link
EP (1) EP1513521A2 (fr)
JP (1) JP2005532337A (fr)
AU (1) AU2002353122B2 (fr)
BR (1) BR0215752A (fr)
CA (1) CA2486832A1 (fr)
MX (1) MXPA04011791A (fr)
WO (1) WO2003101379A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058911A2 (fr) * 2003-12-15 2005-06-30 Alcon, Inc. [1,4]oxazino[2,3-g]indazoles substitues pour traiter le glaucome
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TWI667233B (zh) 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
CA3241845A1 (fr) * 2021-12-24 2023-06-29 Samuel BANISTER Composes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004532887A (ja) * 2001-06-01 2004-10-28 アルコン，インコーポレイテッド 新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用

Also Published As

Publication number Publication date
WO2003101379A2 (fr) 2003-12-11
MXPA04011791A (es) 2005-07-26
CA2486832A1 (fr) 2003-12-11
JP2005532337A (ja) 2005-10-27
EP1513521A2 (fr) 2005-03-16
WO2003101379A3 (fr) 2004-03-04
BR0215752A (pt) 2005-03-29
AU2002353122A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
US6696476B2 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002305732A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002259312B2 (en) Novel arylaminopropane analogues and their use for the treatment of glaucoma
AU2003216760A1 (en) Polycyclic compounds as potent alpha2-adrenoceptor antagonists
CA2447156A1 (fr) Indazoles et indoles nouveaux fusionnes et leur utilisation dans le traitement de glaucomes
AU2003300915B2 (en) Novel benzopyran analogs and their use for the treatment of glaucoma
AU2002353122B2 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2001216034B2 (en) Pyranoindoles for treating glaucoma
WO2005058911A2 (fr) [1,4]oxazino[2,3-g]indazoles substitues pour traiter le glaucome
US7425572B2 (en) Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
HK1061212B (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002305764A1 (en) Novel fused indazoles and indoles and their use for the treatment of glaucoma

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired